Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°©»ó¼± Á¾¾ç¿¡¼­ÀÇ p27kip1ÀÇ ¹ßÇö Expression of p27kip1 in the Thyroid Neoplasms

´ëÇÑ¿Ü°úÇÐȸÁö 2001³â 60±Ç 4È£ p.386 ~ 390
À¯Á¾¿ø, Â÷¼ºÀç, ¹Ú¼ºÁØ, ¹Ú¼ºÀÏ, ÀÌÅÂÁø, ÀÓÇö¹¬,
¼Ò¼Ó »ó¼¼Á¤º¸
À¯Á¾¿ø ( Yoo Jong-Won ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Â÷¼ºÀç ( Cha Sung-Jae ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹Ú¼ºÁØ ( Park Sung-Jun ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹Ú¼ºÀÏ ( Park Sung-Il ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÀÌÅÂÁø ( Lee Tae-Jin ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÓÇö¹¬ ( Lim Hyun-Muk ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: Cyclin-dependent kinase inhibitor, p27kip1 is an important cell-cycle regulator. In recent studies, the loss of p27kip1 expression has been examined in many neoplasms including colorectal cancer and breast cancer. The aims of this study are to evaluate the correlation between p27 expression and carcinogenesis of the thyroid gland and to determine its clinical applications.

Methods: Immunohistochemical staining for p27kip1 was performed in 10 nodular goiters, 12 follicular adenomas, 8 minimally invasive follicular carcinomas, 6 widely invasive follicular carcin
omas, and 26 papillary carcinomas.

Results: p27kip1 was expressed in 90.0% (9/10) of nodular goiters, 66.7% (8/12) of follicular adenomas, 62.5% (5/8) of minimally invasive follicular carcinomas, 33.3% (2/6) of widely invasive follicular carcinomas, and 46.2% (12/26) of papillary carcinomas (P£¾0.05). The expression of p27kip1 was not found to be correlated with tumor size in either neoplasms or nodal metastasis in papillary carcinoma.

Conclusion: These results suggest that p27kip1 does play some role in the tumorigenesis of thyroid cancer but is not a prognostic factor.

Å°¿öµå

p27kip1;°©»ó¼± Á¾¾ç
p27kip1;Thyroid neoplasm

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS